foxo4-dri cancer FOXO4-DRI: Human Trial Status, Research & Senolytic Data FOX04-DRI - Apollo Peptide Sciences
FOX04 DRI Apollo Peptide Sciences foxo4 dri cancer Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic FOXO4 DRI Peptide 10 mg Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





